search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
Collaboration to Accelerate NGS and Immunology Diagnostic Tools Announced


Mayo Clinic, a nonprofi t organisation committed to innovation in clinical practice, education and research, and Thermo Fisher Scientifi c have joined forces to bring innovative solutions to patients by accelerating clinical validation, and commercialisation of selected next-generation sequencing (NGS), mass spectrometry and immunology diagnostic tools. The Advanced Diagnostics Laboratory in One Discovery Square, which is part of the Destination Medical Center initiative, will be the home for this collaboration.


“By pairing cutting-edge, innovative technologies with world-class clinical and diagnostic testing knowledge, this collaboration will ensure that the promising innovations are both clinically relevant and accessible globally,” said William Morice II, MD, PhD, chair of Mayo Clinic’s Department of Laboratory Medicine and Pathology and President of Mayo Clinic Laboratories.


The Mayo Clinic and Thermo Fisher teams are working closely to identify candidate solutions for clinical validation and global commercialisation as part of the collaboration.


“We are excited to join forces with Mayo Clinic to accelerate access to precise and affordable diagnostics for patients across the globe,” said Gianluca Pettiti, Senior Vice President and President, Specialty Diagnostics at Thermo Fisher. “The collaborative effort will leverage NGS, mass spectrometry and immunology technologies to advance haematology, oncology, allergy and autoimmunity diagnostics.”


Mayo Clinic and Thermo Fisher are evaluating diagnostic solutions for multiple applications, including myeloid leukaemia and therapeutic drug monitoring panels to deliver access to more precise and personalised insights for patient care.


55037pr@reply-direct.com


Lauda Announces Better Basics Start-up Investment


requirements in the fi eld of laboratory equipment. The SmartRack organisation system, for example, can be equipped with 3D-printed modules as needed, providing holders for pipettes, round-bottom fl asks or waste containers. The modules can be freely combined in terms of quantity and position. In cooperation with BBL, Lauda can offer customer-centric product solutions.


The cooperation is also intended to expand the technology expertise in 3D printing within the Lauda Group. “The start-up cooperation with Better Basics Laborbedarf provides further access to innovative technologies, which, in addition to synergies with our research and development department, also provides new impetus directly in sales,” said Robert Tietze, Start-Up Manager at Lauda. Lauda is already using 3D printing in the series production of its temperature control units.


Dr Gunther Wobser, President and CEO of Lauda (right), together with Mario Schneider, CEO at Better Basics Laborbedarf (centre) and Robert Tietze, Start-up Manager at Lauda.


Lauda announces a cooperation with Better Basics Laborbedarf GmbH (BBL). The Dresden-based company develops, manufactures and sells smart basic equipment for laboratories that simplifi es the organisation of laboratory workstations and supports laboratory employees in their daily work with individually manufactured organisational systems. The modular systems are produced using 3D printing technology. In addition to an equity investment, Lauda is primarily focusing on synergies for the jointly addressed laboratory market.


Thanks to its in-depth expertise in 3D printing technology and the materials used in this process, the start-up BBL is able to realise individual customer


“A central aspect of Lauda’s innovation strategy is the targeted cooperation with innovative, young companies that complement and further advance our core competence, temperature control,” explained Dr Gunther Wobser, President and CEO of Lauda. “With Better Basics, we have once again made a fi nd and can offer customer-specifi c solutions to the laboratory market. In addition, we expect to gain valuable insights in the fi eld of 3D printing for the production of our temperature control units.”


“We at Better Basics Laborbedarf are very pleased to have gained a strategic partner in Lauda, who will support us in our further growth. In this way, we can benefi t from Lauda’s many years of experience and exploit synergies in sales, among other things,” said Mario Schneider, CEO of Better Basics Laborbedarf.


More information online: ilmt.co/PL/QaWn 55012pr@reply-direct.com


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124  |  Page 125  |  Page 126  |  Page 127  |  Page 128  |  Page 129  |  Page 130  |  Page 131  |  Page 132  |  Page 133  |  Page 134  |  Page 135  |  Page 136  |  Page 137  |  Page 138  |  Page 139  |  Page 140  |  Page 141  |  Page 142  |  Page 143  |  Page 144  |  Page 145  |  Page 146  |  Page 147  |  Page 148  |  Page 149  |  Page 150  |  Page 151  |  Page 152  |  Page 153  |  Page 154  |  Page 155  |  Page 156  |  Page 157  |  Page 158  |  Page 159  |  Page 160  |  Page 161  |  Page 162  |  Page 163  |  Page 164  |  Page 165  |  Page 166  |  Page 167  |  Page 168  |  Page 169  |  Page 170  |  Page 171  |  Page 172  |  Page 173  |  Page 174  |  Page 175  |  Page 176  |  Page 177  |  Page 178  |  Page 179  |  Page 180  |  Page 181  |  Page 182  |  Page 183  |  Page 184  |  Page 185  |  Page 186  |  Page 187  |  Page 188  |  Page 189  |  Page 190  |  Page 191  |  Page 192  |  Page 193  |  Page 194  |  Page 195  |  Page 196